These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 6456228)

  • 21. Staphylococcus aureus isolates from patients with nonmenstrual toxic shock syndrome. Evidence for additional toxins.
    Garbe PL; Arko RJ; Reingold AL; Graves LM; Hayes PS; Hightower AW; Chandler FW; Broome CV
    JAMA; 1985 May; 253(17):2538-42. PubMed ID: 3981783
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Toxic shock syndrome toxin-1 producing strains of Staphylococcus aureus in vaginal smears].
    Dickgiesser N; Brombacher A; Wiest W
    Geburtshilfe Frauenheilkd; 1987 Feb; 47(2):104-6. PubMed ID: 3569835
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alpha-toxin promotes Staphylococcus aureus mucosal biofilm formation.
    Anderson MJ; Lin YC; Gillman AN; Parks PJ; Schlievert PM; Peterson ML
    Front Cell Infect Microbiol; 2012; 2():64. PubMed ID: 22919655
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A new staphylococcal enterotoxin, enterotoxin F, associated with toxic-shock-syndrome Staphylococcus aureus isolates.
    Bergdoll MS; Crass BA; Reiser RF; Robbins RN; Davis JP
    Lancet; 1981 May; 1(8228):1017-21. PubMed ID: 6112412
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Binding of type-I and type-II collagens to Staphylococcus aureus strains isolated from patients with toxic shock syndrome compared to other staphylococcal infections.
    Naidu AS; Ekstrand J; Wadström T
    FEMS Microbiol Immunol; 1989 Mar; 1(4):219-27. PubMed ID: 2629906
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Toxicity of recombinant toxic shock syndrome toxin 1 and mutant toxins produced by Staphylococcus aureus in a rabbit infection model of toxic shock syndrome.
    Bonventre PF; Heeg H; Cullen C; Lian CJ
    Infect Immun; 1993 Mar; 61(3):793-9. PubMed ID: 8432600
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quantitative vaginal microflora in women convalescent from toxic shock syndrome and in healthy controls.
    Chow AW; Bartlett KH; Goldring AM
    Infect Immun; 1984 Jun; 44(3):650-2. PubMed ID: 6724691
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Toxic shock syndrome and lysogeny in Staphylococcus aureus.
    Schutzer SE; Fischetti VA; Zabriskie JB
    Science; 1983 Apr; 220(4594):316-8. PubMed ID: 6220467
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chitosan malate inhibits growth and exotoxin production of toxic shock syndrome-inducing Staphylococcus aureus strains and group A streptococci.
    Schlievert PM
    Antimicrob Agents Chemother; 2007 Sep; 51(9):3056-62. PubMed ID: 17576832
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunological protection of rabbits infected with Staphylococcus aureus isolates from patients with toxic shock syndrome.
    Scott DF; Kling JM; Best GK
    Infect Immun; 1986 Aug; 53(2):441-4. PubMed ID: 3733224
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Staphylococcus aureus producing toxic shock syndrome toxin 1 (TSST-1) in clinical specimens and vaginal swabs in Mannheim, West Germany.
    Dickgiesser N; Brombacher A
    Zentralbl Bakteriol Mikrobiol Hyg A; 1987 Jul; 265(3-4):323-9. PubMed ID: 3314262
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protein antigens from Staphylococcus aureus strains associated with toxic-shock syndrome.
    Cohen ML; Falkow S
    Science; 1981 Feb; 211(4484):842-4. PubMed ID: 7466361
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Staphylococcal pyrogenic exotoxin type C: further characterization.
    Schlievert PM; Kelly JA
    Ann Intern Med; 1982 Jun; 96(6 Pt 2):982-6. PubMed ID: 7091979
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection of staphylococcal enterotoxin B among toxic shock syndrome (TSS)- and non-TSS-associated Staphylococcus aureus isolates.
    Lee VT; Chang AH; Chow AW
    J Infect Dis; 1992 Oct; 166(4):911-5. PubMed ID: 1527429
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of vaginal microbial communities on colonization by Staphylococcus aureus with the gene for toxic shock syndrome toxin 1 (TSST-1): a case-control study.
    Pierson JD; Hansmann MA; Davis CC; Forney LJ
    Pathog Dis; 2018 Jun; 76(4):. PubMed ID: 29762733
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Lethal, non-menstrual toxic shock syndrome associated with Staphylococcus aureus sepsis].
    Raumanns J; Kaufhold A; Behrendt W; Peters G
    Anaesthesist; 1995 Dec; 44(12):869-74. PubMed ID: 8594962
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Staphylococcus aureus associated with toxic shock syndrome: phage typing and toxin capability testing.
    Altemeier WA; Lewis SA; Schlievert PM; Bergdoll MS; Bjornson HS; Staneck JL; Crass BA
    Ann Intern Med; 1982 Jun; 96(6 Pt 2):978-82. PubMed ID: 6212008
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vaginal tampon model for toxic shock syndrome.
    Melish ME; Murata S; Fukunaga C; Frogner K; McKissick C
    Rev Infect Dis; 1989; 11 Suppl 1():S238-46; discussion S246-7. PubMed ID: 2928642
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Group B streptococcal toxic shock-like syndrome: report of a case and purification of an associated pyrogenic toxin.
    Schlievert PM; Gocke JE; Deringer JR
    Clin Infect Dis; 1993 Jul; 17(1):26-31. PubMed ID: 8353243
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Microbiology of toxic shock syndrome: overview.
    See RH; Chow AW
    Rev Infect Dis; 1989; 11 Suppl 1():S55-60. PubMed ID: 2648541
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.